Influence of a continuous prednisolone medication on the time course of neuromuscular block of atracurium in patients with chronic inflammatory bowel disease

British Journal of Anaesthesia

Volumn 100, Issue 6, 2008, Pages 798-802

  Soltesz S ^a   Mencke, T ^b   Mey, C ^a   Rohrig S ^a   Diefenbach, C ^c   Molter, G P ^a  

^a Hospital of Leverkusen   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c St Katharinen Hospital   (Germany)

Author keywords

Neuromuscular block, atracurium; Neuromuscular block, recovery

Indexed keywords

ATRACURIUM; C REACTIVE PROTEIN; FENTANYL; LORAZEPAM; NEUROMUSCULAR BLOCKING AGENT; PREDNISOLONE; PROPOFOL; REMIFENTANIL;

ABDOMINAL SURGERY; ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 44649147776     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen084     Document Type: Article

References (25)

1. Kindler CH, Verotta D, Gray AT, Gropper MA, Yost CS. Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium. Anesthesiology 2000; 92: 821-32
2. Shima H. The effect of corticosteroids on the recovery from vecuronium induced block. Masui 1990; 39: 619-25
3. Paradiso K, Sabey K, Evers AS, Zorumski CF, Covey DF, Steinbach JH. Steroid inhibition of rat neuronal nicotinic alpha4beta2 receptors expressed in HEK 293 cells. Mol Pharmacol 2000; 58: 341-51
4. Feldman S, Karalliedde L. Drug interactions with neuromuscular blockers. Drug Saf 1996; 15: 261-73
5. Leeuwin RS, Veldsema-Currie RD, van Wilgenburg H, Ottenhof M. Effects of corticosteroids on neuromuscular blocking actions of d-tubocurarine. Eur J Pharmacol 1981; 69: 165-73
6. Dal Belo CA, Leite GB, Fontana MD, et al. New evidence for a presynaptic action of prednisolone at neuromuscular junctions. Muscle Nerve 2002; 26: 37-43
7. Blobner M, Kochs E, Fink H, et al. Pharmacokinetics and pharmacodynamics of vecuronium in rats with systemic inflammatory response syndrome: treatment with NG-monomethyl-L-arginine. Anesthesiology 1999; 91: 999-1005
8. Narimatsu E, Nakayama Y, Sumita S, et al. Sepsis attenuates the intensity of the neuromuscular blocking effect of d-tubocurarine and the antagonistic actions of neostigmine and edrophonium accompanying depression of muscle contractility of the diaphragm. Acta Anaesthesiol Scand 1999; 43: 196-201
9. Viby-Mogensen J, Engbaek J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996; 40: 59-74
10. Bock M, Klippel K, Nitsche B, Bach A, Martin E, Motsch J. Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaesthesia. Br J Anaesth 2000; 84: 43-7
11. Parr SM, Robinson BJ, Rees D, Galletly DC. Interaction between betamethasone and vecuronium. Br J Anaesth 1991; 67: 447-51
12. Hall ED. Glucocorticoid effects on the electrical properties of spinal motor neurons. Brain Res 1982; 240: 109-16
13. Veldsema-Currie RD, Wolters E, Leeuwin RS. The effect of corticosteroids and hemicholinium-3 on choline uptake and incorporation into acetylcholine in rat diaphragm. Eur J Pharmacol 1976; 35: 399-402
14. Dalkara T, Onur R. Facilitatory effects of dexamethasone on neuromuscular transmission. Exp Neurol 1987; 95: 116-25
15. Dreyer F, Peper K, Sterz R, Bradley RJ, Muller KD. Drug-receptor interaction at the frog neuromuscular junction. Prog Brain Res 1979; 49: 213-23
16. Wilson RW, Ward MD, Johns TR. Corticosteroids: a direct effect at the neuromuscular junction. Neurology 1974; 24: 1091-5
17. Davis NA, Rodgers JE, Gonzalez ER, Fowler AA III. Prolonged weakness after cisatracurium infusion: a case report. Crit Care Med 1998; 26: 1290-2
18. Fischer JR, Baer RK. Acute myopathy associated with combined use of corticosteroids and neuromuscular blocking agents. Ann Pharmacother 1996; 30: 1437-45
19. Meyer KC, Prielipp RC, Grossman JE, Coursin DB. Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 1994; 78: 772-4
20. Yasukawa T, Kaneki M, Yasuhara S, Lee SL, Martyn JA. Steroidal nondepolarizing muscle relaxants do not simulate the effects of glucocorticoids on glucocorticoid receptor-mediated transcription in cultured skeletal muscle cells. Anesthesiology 2004; 100: 1615-9
21. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007; 51: 789-808
22. Fuchs-Buder T, Sparr HJ, Ziegenfuss T. Thiopental or etomidate for rapid sequence induction with rocuronium. Br J Anaesth 1998; 80: 504-6
23. Parr SM, Galletly DC, Robinson BJ. Betamethasone-induced resistance to vecuronium: a potential problem in neurosurgery? Anaesth Intensive Care 1991; 19: 103-5
24. Koenig HM, Hoffman WE. The effect of anticonvulsant therapy on two doses of rocuronium-induced neuromuscular blockade. J Neurosurg Anesthesiol 1999; 11: 86-9
25. Wright PM, McCarthy G, Szenohradszky J, Sharma ML, Caldwell JE. Influence of chronic phenytoin administration on the pharmacokinetics and pharmacodynamics of vecuronium. Anesthesiology 2004; 100: 626-33